API

APIXABAN is an anticoagulant medication used to treat and prevent blood clots and to prevent stroke in people with nonvalvular atrial fibrillation through directly inhibiting factor Xa.

Products still subject to third-party patent protection might be available solely for R&D purposes.

TERBINAFINE HCL is an antifungal medication used to treat pityriasis versicolor, fungal nail infections, and ringworm, including jock itch and athlete's foot.

Products still subject to third-party patent protection might be available solely for R&D purposes.

RACECADOTRIL is an antidiarrheal medication which acts as a peripheral enkephalinase inhibitor. RACECADOTRIL has an antisecretory effect - it reduces the secretion of water and electrolytes into the intestine.

Products still subject to third-party patent protection might be available solely for R&D purposes.

As a novel potassium-competitive acid blocker, VONOZOPRAN FUMARATE may provide reversible acid suppression by preventing K+ from binding to gastric H+/K+-ATPase. It has been clinically used for the short-term treatment of gastroesophageal reflux disease (GERD), peptic ulcer disease and Helicobacter pylori (H. pylori) infection.

Products still subject to third-party patent protection might be available solely for R&D purposes.

MOSAPRIDE CITRATE is a gastroprokinetic agent that acts as a selective 5HT4 agonist. The major active metabolite of mosapride, known as M1, additionally acts as a 5HT3 antagonist, which accelerates gastric emptying throughout the whole of the gastrointestinal tract in humans.

Products still subject to third-party patent protection might be available solely for R&D purposes.

RABEPRAZOLE SODIUM HYDRATE is a medication that decreases stomach acid. it is used to treat peptic ulcer disease, gastroesophageal reflux disease, and excess stomach acid production.

Products still subject to third-party patent protection might be available solely for R&D purposes.